FDA Notifies Processors of Recall of Fancy Whole Basil Due to Possible Health Risk

Article

The U.S. Food and Drug Administration (FDA) is advising processors and repackers that Majestic International Spice Corporation is voluntarily recalling its dried Extra Fancy Basil spice in 12.5 kilogram bags because the FDA found the product contaminated with Salmonella Blockley.  Salmonella is a well-known cause of both outbreaks and sporadic disease in various parts of the world and as such poses a potential health threat. FDA is issuing this advisory because we are concerned that the firm has not adequately alerted its consignees to the problem.

The only identification on the 12.5 kilogram paper bags is a white paper label stating EXTRA FANCY BASIL 12.5 KGS.  The exact dates of sale are unknown but we believe the product was sold beginning in late April 2005.

Salmonella is a microorganism that can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella bacteria often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the microorganism getting into the bloodstream and producing more severe illnesses such as arterial infections, endocarditis and arthritis.

No illnesses have been reported to date in connection with this problem.

The contamination was noted after routine testing by FDA revealed the presence of Salmonella Blockley. The recall was the result of the FDA sampling. The company has ceased the distribution of the product in question.

Processors or repackers who received this product should discontinue using it and contact their local FDA office. 

Source: FDA

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content